SCHEMBL7246353

SCHEMBL7246353

CCCCCCCCCCCCN(C)CCCS(=O)(=O)O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
S1PR2 O95136 1/20 0.52
S1PR1 P21453 1/20 0.52
S1PR3 Q99500 1/20 0.52
S1PR5 Q9H228 1/20 0.52
GGPS1 O95749 4/20 0.44
KDM4C Q9H3R0 6/20 0.44
KDM5A P29375 5/20 0.44
PHF8 Q9UPP1 2/20 0.44
FDPS P14324 1/20 0.43
AGTR1 P30556 1/20 0.43
OPRM1 P35372 1/20 0.43
PDE3A Q14432 1/20 0.43
DNM1 Q05193 3/20 0.43
EPHX2 P34913 1/20 0.42
KDM5C P41229 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
KDM4A O75164 2/20 0.40
FAAH O00519 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27518580 1.00 S1PR2 (0.52) S1PR2S1PR1S1PR3S1PR5GGPS1
SCHEMBL15939355 1.00 S1PR2 (0.52) S1PR2S1PR1S1PR3S1PR5GGPS1
SCHEMBL27730840 1.00 S1PR2 (0.52) S1PR2S1PR1S1PR3S1PR5GGPS1
SCHEMBL13155350 1.00 S1PR2 (0.52) S1PR2S1PR1S1PR3S1PR5GGPS1
SCHEMBL16311730 1.00 S1PR2 (0.52) S1PR2S1PR1S1PR3S1PR5GGPS1
SCHEMBL17817349 1.00 S1PR2 (0.52) S1PR2S1PR1S1PR3S1PR5GGPS1
SCHEMBL5339485 1.00 S1PR2 (0.52) S1PR2S1PR1S1PR3S1PR5GGPS1
SCHEMBL17453161 1.00 S1PR2 (0.52) S1PR2S1PR1S1PR3S1PR5GGPS1
SCHEMBL11553105 1.00 S1PR2 (0.52) S1PR2S1PR1S1PR3S1PR5GGPS1
SCHEMBL15870622 0.98 S1PR2 (0.48) S1PR2S1PR1S1PR3S1PR5GGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109423266-A A kind of amphoteric ion spherex and its preparation method and application 中国石油化工股份有限公司 2019-03-05 CN claimed
EP-4258056-A2 ALCOHOL COMPOUND, CHEMICALLY AMPLIFIED NEGATIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-10-11 EP disclosed
EP-4198630-A1 CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2023-06-21 EP disclosed
CN-114713056-A System and method for continuous flow emulsion processing 滴管公司 2022-07-08 CN disclosed
EP-3229811-B1 PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS GRI BIO INC (US) 2021-02-24 EP disclosed
CN-109422886-A A kind of anion doped spherex material and its preparation method and application 中国石油化工股份有限公司 2019-03-05 CN disclosed
CN-109422851-A A kind of cationic starch microballoon and its preparation method and application 中国石油化工股份有限公司 2019-03-05 CN disclosed
CN-109422887-A A kind of anionic starch microballoon and its preparation method and application 中国石油化工股份有限公司 2019-03-05 CN disclosed
CN-109423265-A A kind of anti-salt temperature-resistant spherex and its preparation method and application 中国石油化工股份有限公司 2019-03-05 CN disclosed
EP-2813854-B1 HEMOLYSIS REAGENT COMPOSITION FOR HEMOGLOBIN A1C QUANTITATIVE ANALYSIS USING ENZYMATIC METHOD I SENS INC (KR) 2016-09-07 EP disclosed
US-20150203441-A1 CHOLATE AND DEOXYCHOLATE-BASED AMPHIPHILES FOR MEMBRANE PROTEIN MANIPULATION WISCONSIN ALUMNI RESEARCH FOUNDATION 2015-07-23 US disclosed
EP-2813854-A1 HEMOLYSIS REAGENT COMPOSITION FOR HEMOGLOBIN A1C QUANTITATIVE ANALYSIS USING ENZYMATIC METHOD i-Sens, Inc. (KR) 2014-12-17 EP disclosed
CN-1125880-C Method for processing mycobacteria INTEGRATED RES TECH PLC (US) 2003-10-29 CN disclosed
US-6632598-B1 Paraffin-solubilizing organic solvents; tissue samples; histological analysis; aqueous wash solutons; surfactants; use for dewaxing wax-embedded biologial specimens prior to histochemical analysis BIOGENEX LABORATORIES 2003-10-14 US disclosed
CN-1150460-A Method for processing mycobacteria CORNING CLINICAL LAB INC (US) 1997-05-21 CN disclosed
EP-0382875-A1 Dispersant for biologically active peptide Matuo, Yuhsy (JP) 1990-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203441-A1 CHOLATE AND DEOXYCHOLATE-BASED AMPHIPHILES FOR MEMBRANE PROTEIN MANIPULATION CHLSN, CETP, CEL S1PR2 3292/4885S1PR1 2908/4885S1PR3 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.